Proportion of isolates with decreased susceptibility or resistance in Norway

Norway: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile

Latest (2018)
0
Change on year
down 100.0%
World rank
25th
of 51 countries
All-time high
6.52
in 2010
All-time low
0
in 2018
Years of data
10
2009–2018

Proportion of isolates with decreased susceptibility or resistance in Norway, 2009–2018

02462009201320182009: 0.9092010: 6.52011: 1.32012: 5.52013: 4.52014: 5.52015: 0.9092016: 1.82017: 0.92018: 0

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for proportion of isolates with decreased susceptibility or resistance in Norway is 0, measured in 2018. That is the lowest value across all 10 years on record.

Compared with earlier readings it is down 100.0% on the previous year and down 100.0% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Norway peaked at 6.52 in 2010 and was at its lowest, 0, in 2018.

That places Norway 25th out of 51 countries with data for 2018, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Norway, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP in Norway, 2009 to 2018.
Year Value Change
2009 0.9091
2010 6.52 +617.4%
2011 1.3 -80.1%
2012 5.45 +320.0%
2013 4.46 -18.2%
2014 5.45 +22.2%
2015 0.9091 -83.3%
2016 1.8 +98.2%
2017 0.9 -50.0%
2018 0 -100.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.9091 0.9091 0.9091 1
2010s 2.98 0 6.52 9

Countries ranked near Norway

  1. 22 New Zealand 0.4386 compare
  2. 23 United States of America 0.2907 compare
  3. 24 Australia 0.0666 compare
  4. 25 Cuba 0
  5. 25 Slovakia 0 compare
  6. 25 France 0 compare
  7. 25 Colombia 0
  8. 25 Paraguay 0
  9. 25 Malta 0 compare
  10. 25 South Africa 0
  11. 25 Netherlands 0 compare
  12. 25 Slovenia 0 compare
  13. 25 Argentina 0 compare
  14. 25 Côte d'Ivoire 0
  15. 25 Russian Federation 0
  16. 25 Bhutan 0 compare
  17. 25 Portugal 0 compare
  18. 25 Estonia 0
  19. 25 Dominican Republic 0
  20. 25 Latvia 0 compare
  21. 25 Pakistan 0 compare
  22. 25 Peru 0 compare
  23. 25 Chile 0
  24. 25 Iceland 0
  25. 25 Denmark 0 compare
  26. 25 Panama 0
  27. 25 Ireland 0 compare
  28. 25 Sri Lanka 0
  29. 25 Korea 0 compare

See the full ranking of 51 places →

More health data for Norway

All data for Norway →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Norway?
Proportion of isolates with decreased susceptibility or resistance in Norway was 0 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Norway?
The highest recorded value was 6.52 in 2010.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Norway?
The lowest recorded value was 0 in 2018.
How does Norway rank for proportion of isolates with decreased susceptibility or resistance?
Norway ranks 25th out of 51 countries with data for 2018.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in Norway?
Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
Where does this Norway data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Norway. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 10 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-extended/norway/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-extended/norway/">Proportion of isolates with decreased susceptibility or resistance in Norway</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
51 places, 436 data points, 2009–2018
Last refreshed